J&J wins Pfizer consumer health unit
456344
Johnson &amp; Johnson  said  on Monday it would buy Pfizer Inc.&#039;s  consumer  health-care business for &#36;16.6 billion in cash to increase its  lead in the market for non-prescription health products.
732632
By Kyodo News International, Tokyo  Mar. 6--TOKYO -- Japan Tobacco Inc. said Tuesday antitrust authorities in  Russia and South Africa have unconditionally approved JT's planned acquisition  of British competitor Gallaher Group Plc.
395582
J&J and Schering revise their agreement over anti-TNF compounds.
574939
Pfizer Inc , the world's biggest drugmaker, on Wednesday reported fourth-quarter results that beat expectations.
249844
CHICAGO/PHILADELPHIA  - Health care and consumer  products maker Johnson & Johnson JNJ.N is in negotiations to  acquire medical-device maker Guidant Corp. GDT.N, sources  familiar with the situation said on Tuesday.
158108
Pfizer Inc , the world's biggest drug maker, on Wednesday reported fourth-quarter results that beat expectations, sending its shares higher in premarket trading.
416523
Johnson &amp; Johnson (JNJ:NYSE - news - research) said Tuesday that the Food and Drug Administration had approved its Charite artificial disc, the first such device for treating lower back pain.
85267
Johnson &amp; Johnson agreed to acquire Guidant Corp. for $25.4 billion, adding electrical devices for treating heart disease to a lineup of thousands of health products including Band-Aids and cardiac stents.
382436
Drug giant Pfizer Inc. reiterated Thursday that its arthritis drug Celebrex was safe to use after competitor Merck &amp; Co. pulled its arthritis drug Vioxx off the market worldwide after studies showed it raised the risk of heart attack.
101354
A day after Whitehouse Station-based Merck abruptly withdrew from the market Vioxx, its blockbuster arthritis drug, Pfizer yesterday moved to promote Celebrex, its competing medicine.
484469
Pfizer Inc. shares rebounded on  Tuesday as a study of Alzheimer's patients found that its  arthritis drug Celebrex carried no increased cardiovascular  risks, differing from findings of a study in cancer patients  released last week.
193591
NEW BRUNSWICK, N.J.  -- Health care products maker Johnson & Johnson on Tuesday posted a fourth-quarter profit increase of nearly 10 percent as revenues jumped by double digits despite declines in sales of two key product lines.
753841
A New Jersey jury found on Monday that  Merck & Co. Inc.'s  withdrawn arthritis drug Vioxx was  responsible for a plaintiff's heart attack and it awarded $20  million in compensatory damages.
760968
Johnson & Johnson  and a unit  of Pfizer Inc.  agreed to sell the U.S. rights to five  brands, including Balmex diaper rash treatment, to Chattem Inc.   for $410 million to satisfy regulatory requirements,  Chattem said on Friday.
478171
INDIANAPOLIS - Health care products giant Johnson &amp; Johnson&#39;s $25.4 billion acquisition of Guidant Corp., formally announced Thursday, could face a tough review from regulators because of their competition in the coronary stent market, analysts say.
693412
Pfizer&#39;s schizophrenia drug Geodon (ziprasidone HCI) has won new US Food and Drug Administration approval to treat bipolar mania, a condition characterized by unnatural
585106
Pfizer Inc. won U.S. approval on Thursday to promote its prescription drug Lyrica for treating fibromyalgia, a chronic disease which can cause debilitating pain, sleep problems, stiffness and fatigue.